Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for neuromuscular disease caused by qualitative or quantitative defects of protein SERCA1 has been reported in the published literature.
No clinical trials have been registered for neuromuscular disease caused by qualitative or quantitative defects of protein SERCA1.
121 publications have been identified in PubMed for neuromuscular disease caused by qualitative or quantitative defects of protein SERCA1. Kisho has analyzed 57 by research type. Research spans Other (54%), Review / Meta-Analysis (23%), and Epidemiology / Natural History (9%).
Research Type | Count | % of Total |
|---|---|---|
Other research | 31 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 9:33 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 13 | 23% |
Disease patterns and progression | 5 | 9% |
Laboratory research | 4 | 7% |
Testing and diagnosis research | 3 | 5% |
Clinical study results | 1 | 2% |
Schoser B (2026). [PMID: 41689635](https://pubmed.ncbi.nlm.nih.gov/41689635/). *J Neurol*. [Review / Meta-Analysis]
Kramarz C (2026). [PMID: 42231561](https://pubmed.ncbi.nlm.nih.gov/42231561/). *J Peripher Nerv Syst*. [Epidemiology / Natural History]
van der Laan TMJ (2026). [PMID: 41973741](https://pubmed.ncbi.nlm.nih.gov/41973741/). *PLoS One*. [Epidemiology / Natural History]
Bashirov R (2026). [PMID: 42178473](https://pubmed.ncbi.nlm.nih.gov/42178473/). *Adv Exp Med Biol*. [Review / Meta-Analysis]
Antonson C (2026). [PMID: 41988564](https://pubmed.ncbi.nlm.nih.gov/41988564/). *Front Public Health*. [Other]
Demirkol H (2026). [PMID: 41124361](https://pubmed.ncbi.nlm.nih.gov/41124361/). *J Back Musculoskelet Rehabil*. [Other]
Hoffman RJ (2026). [PMID: 41592939](https://pubmed.ncbi.nlm.nih.gov/41592939/). *Arch Dis Child*. [Review / Meta-Analysis]
Paroli M (2026). [PMID: 41432692](https://pubmed.ncbi.nlm.nih.gov/41432692/). *J Neurophysiol*. [Other]
Allergodt K (2026). [PMID: 40842110](https://pubmed.ncbi.nlm.nih.gov/40842110/). *Disabil Rehabil*. [Other]
Hayward CPM (2025). [PMID: 41348029](https://pubmed.ncbi.nlm.nih.gov/41348029/). *Hematology Am Soc Hematol Educ Program*. [Review / Meta-Analysis]